Navigation Links
More kidney cancer is detected and treated early, yet death rate rises

e explained, in part, through the rising incidence of larger, more lethal tumors, says lead author John M. Hollingsworth, M.D., fifth-year surgery resident with the Department of Urology at the U-M Medical School. "While more and more small, detectable kidney tumors are being treated, the absolute number of patients with larger, lethal masses has not decreased. And it is these larger, lethal masses that seem to mainly affect mortality," Hollingsworth says.

The researchers say the data also suggest something else: A proportion of these smaller, incidentally found kidney tumors may not merit surgical removal.

"We're not saying that surgery for patients with small renal masses is inappropriate," Hollingsworth says. "Our findings, however, show that their increased treatment has not diminished kidney cancer mortality. This calls to question the effectiveness of our current treatment strategy. Perhaps there are some patients with small kidney tumors for whom surgery is not the best option."

Kidney cancer is the third most common malignancy of the genitourinary system (the reproductive system and urinary system). The American Cancer Society estimates there will be about 38,890 new cases of kidney cancer (24,650 in men and 14,240 in women) in the United States this year, and about 12,840 people (8,130 men and 4,710 women) will die from the disease.

This study included data from 34,503 kidney cancer patients, including age at diagnosis, race, gender and information about the tumor. During the years 1983-2002, researchers found, the overall incidence of kidney cancer rose from 7.1 to 10.8 cases per 100,000 people in the United States, an increase of 52 percent. The largest increase was among people with tumors 2 to 4 centimeters in size (the second-smallest category of tumors in the study), an increase of 1.0 to 3.3 cases per 100,000 people in the United States.

Mortality rates also increased, most notably among people with the
'"/>

Source:University of Michigan Health System


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
3. NASA links nanobacteria to kidney stones and other diseases
4. New type of rejection blocker protects kidneys after transplant
5. New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease
6. Scientists discover that widely available drug also helps fight kidney disease
7. Gene discovery may shed light on kidney disease
8. U of M study examines kidney stone prevention in astronauts
9. Scientists solve 30-year-old mystery of mutant mouses kidney woes
10. Key gene controlling kidney development found
11. Mutant gene causes severe kidney disease in infants
Post Your Comments:
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Research team finds first evolutionary branching for bilateral animals 10060 1Research team finds first evolutionary branching for bilateral animals 10060 2Hand Washing Habits Still Need Improvement 3A Survey 58146 1NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 1NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 2NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 3
...journal PLoS Biology has been assessed by Thomson ...s PLoS Biology among the most highly cited journal...tistic for a journal less than two years old, from...at supports open access to the scientific and medi...PLoS Biology above such established journals as EM...
...es matters after all. But for flying snakes, small...esearchers. , In the May 15, 2005, issue of the J...ed the effects of size and behavior of flying snak... gliders. , "Despite their lack of wing-like appen...," said lead scientist and author Jake Socha, Ph.D...
...cent of women rely on their healthcare providers t...rcent said their doctor has talked to them about c...virus (HPV) - according to a new survey released b...nals (ARHP). HPV is extremely common, affecting an... their lifetime, in some cases staying dormant unt...
Other Biology News:The first impact factor for PLoS Biology ?13.9 2Researchers reveal secrets of flying snakes 2Researchers reveal secrets of flying snakes 3Survey reveals women and doctors aren't talking about HPV 2Survey reveals women and doctors aren't talking about HPV 3
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...new research field called transformation optics ma...cloak of invisibility and ultra-powerful microscop..."metamaterials." , The field, which applies mathe...theory of general relativity, will be described in...e journal Science . The article will appear in th...
...ceutical,Laboratories, Ltd. (Amex: CPD ) announce...its second quarter of fiscal year 2009, ended Sept...troit-based Caraco Pharmaceutical Laboratories, Lt... generic and private-label,pharmaceuticals to the ...re chains and managed care providers., Safe Harbo...
...nalytical Technologies,Inc. (AATI), based in Ames,...ding an additional 1200 ft2 of space to current op... space the company occupies in Building 4 on the,I...0 year old analytical,instrumentation company will...earch Park Campus, the expansion will make the com...
Other Biology Technology:New research field promises radical advances in optical technologies 2New research field promises radical advances in optical technologies 3New research field promises radical advances in optical technologies 4Caraco Pharmaceutical Laboratories Ltd. to Announce Second Quarter of Fiscal Year 2009 Results on October 23, 2008 2Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space 2
Custom Production Service - Purification from AbD Serotec
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Rat Big Endothelin-1 (Big ET-1) EIA Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: